Radiolabeled Compounds for Diagnosis and Treatment of Cancer

Radiolabeled Compounds for Diagnosis and Treatment of Cancer

Radiopharmaceuticals are used in the diagnosis and treatment of various diseases, especially cancer. In general, radiopharmaceuticals are either salts of radionuclides or radionuclides bound to biologically active molecules, drugs, or cells. Tremendous progress has been made in discovering, developi...

Full description

Saved in:
Bibliographic Details
Sonstige:
Kumar, Krishan
Year of Publication:2021
Language:English
Physical Description:1 electronic resource (262 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993546243204498
ctrlnum (CKB)5400000000044428
(oapen)https://directory.doabooks.org/handle/20.500.12854/77048
(EXLCZ)995400000000044428
collection bib_alma
record_format marc
spelling Kumar, Krishan edt
Radiolabeled Compounds for Diagnosis and Treatment of Cancer
Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021
1 electronic resource (262 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Radiopharmaceuticals are used in the diagnosis and treatment of various diseases, especially cancer. In general, radiopharmaceuticals are either salts of radionuclides or radionuclides bound to biologically active molecules, drugs, or cells. Tremendous progress has been made in discovering, developing, and commercializing numerous radiopharmaceuticals for the imaging and therapy of cancer. Significant research is ongoing in academia and the pharmaceutical industry to develop more novel radiolabeled compounds as potential radiopharmaceuticals for unmet needs. This Special Issue aims to focus on all aspects of the design, characterization, evaluation, and development of novel radiolabeled compounds for the diagnosis and treatment of cancer and the application of new radiochemistry and methodologies for the development of novel radiolabeled compounds. Outstanding contributions presented in this Special Issue will significantly add to the field of radiopharmaceuticals.
English
Research & information: general bicssc
Chemistry bicssc
positron emission tomography (PET)
pyrazoles
fluorine-18
radionuclides
PET probes
imaging pharmaceuticals
hypopharyngeal cancer
188Re-liposome
repeated therapy
NGS
microRNA
aprepitant
radiopharmaceuticals
neurokinin 1 receptor antagonist
radionuclide chelators
kidney uptake
cleavable linkers
neutral endopeptidase (NEP)
renal brush border enzymes
prostate-specific membrane antigen (PSMA)
cancer imaging and therapy
somatostatin analogs
radiolabeling
radionuclide therapy
imaging
adrenergic receptor
positron emission tomography
radiotracer
cholecystokinin-2 receptor
minigastrin
molecular imaging
targeted radiotherapy
lutetium-177
EpCAM
radionuclide
SPECT
iodine
PIB
breast
cancer
PET
target-specific biomolecules
immunoPET imaging pharmaceuticals
production processes
124I-labeled monoclonal antibodies
radiotracers
AAZTA
scandium-44
FAP
SA
DPP
PREP
radioiodine labeling
radioiodination
biomolecules
peptides
proteins
monoclonal antibodies
123,124,125,131I-labeled molecules and biomolecules
3-0365-2427-4
3-0365-2426-6
Kumar, Krishan oth
language English
format eBook
author2 Kumar, Krishan
author_facet Kumar, Krishan
author2_variant k k kk
author2_role Sonstige
title Radiolabeled Compounds for Diagnosis and Treatment of Cancer
spellingShingle Radiolabeled Compounds for Diagnosis and Treatment of Cancer
title_full Radiolabeled Compounds for Diagnosis and Treatment of Cancer
title_fullStr Radiolabeled Compounds for Diagnosis and Treatment of Cancer
title_full_unstemmed Radiolabeled Compounds for Diagnosis and Treatment of Cancer
title_auth Radiolabeled Compounds for Diagnosis and Treatment of Cancer
title_new Radiolabeled Compounds for Diagnosis and Treatment of Cancer
title_sort radiolabeled compounds for diagnosis and treatment of cancer
publisher MDPI - Multidisciplinary Digital Publishing Institute
publishDate 2021
physical 1 electronic resource (262 p.)
isbn 3-0365-2427-4
3-0365-2426-6
illustrated Not Illustrated
work_keys_str_mv AT kumarkrishan radiolabeledcompoundsfordiagnosisandtreatmentofcancer
status_str n
ids_txt_mv (CKB)5400000000044428
(oapen)https://directory.doabooks.org/handle/20.500.12854/77048
(EXLCZ)995400000000044428
carrierType_str_mv cr
is_hierarchy_title Radiolabeled Compounds for Diagnosis and Treatment of Cancer
author2_original_writing_str_mv noLinkedField
_version_ 1796651409673814016
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03882nam-a2201009z--4500</leader><controlfield tag="001">993546243204498</controlfield><controlfield tag="005">20231214132832.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202201s2021 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000044428</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/77048</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000044428</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kumar, Krishan</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Radiolabeled Compounds for Diagnosis and Treatment of Cancer</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (262 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Radiopharmaceuticals are used in the diagnosis and treatment of various diseases, especially cancer. In general, radiopharmaceuticals are either salts of radionuclides or radionuclides bound to biologically active molecules, drugs, or cells. Tremendous progress has been made in discovering, developing, and commercializing numerous radiopharmaceuticals for the imaging and therapy of cancer. Significant research is ongoing in academia and the pharmaceutical industry to develop more novel radiolabeled compounds as potential radiopharmaceuticals for unmet needs. This Special Issue aims to focus on all aspects of the design, characterization, evaluation, and development of novel radiolabeled compounds for the diagnosis and treatment of cancer and the application of new radiochemistry and methodologies for the development of novel radiolabeled compounds. Outstanding contributions presented in this Special Issue will significantly add to the field of radiopharmaceuticals.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Research &amp; information: general</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chemistry</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">positron emission tomography (PET)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pyrazoles</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fluorine-18</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">radionuclides</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PET probes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">imaging pharmaceuticals</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hypopharyngeal cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">188Re-liposome</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">repeated therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NGS</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">microRNA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">aprepitant</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">radiopharmaceuticals</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neurokinin 1 receptor antagonist</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">radionuclide chelators</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">kidney uptake</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cleavable linkers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neutral endopeptidase (NEP)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">renal brush border enzymes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">prostate-specific membrane antigen (PSMA)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer imaging and therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">somatostatin analogs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">radiolabeling</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">radionuclide therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">imaging</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">adrenergic receptor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">positron emission tomography</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">radiotracer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cholecystokinin-2 receptor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">minigastrin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">molecular imaging</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">targeted radiotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lutetium-177</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">EpCAM</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">radionuclide</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">SPECT</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">iodine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PIB</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">breast</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PET</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">target-specific biomolecules</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunoPET imaging pharmaceuticals</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">production processes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">124I-labeled monoclonal antibodies</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">radiotracers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">AAZTA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">scandium-44</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">FAP</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">SA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">DPP</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PREP</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">radioiodine labeling</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">radioiodination</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biomolecules</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">peptides</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">proteins</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">monoclonal antibodies</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">123,124,125,131I-labeled molecules and biomolecules</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-2427-4</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-2426-6</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kumar, Krishan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:33:00 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338195400004498&amp;Force_direct=true</subfield><subfield code="Z">5338195400004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338195400004498</subfield></datafield></record></collection>

Similar Items